Deutsche Bank AG restated their buy rating on shares of Tenet Healthcare Corporation (NYSE:THC) in a research report report published on Friday. Deutsche Bank AG currently has a $24.00 price target on the stock.

THC has been the topic of a number of other research reports. ValuEngine lowered shares of Tenet Healthcare Corporation from a hold rating to a sell rating in a research note on Friday, June 2nd. Leerink Swann reiterated an outperform rating and issued a $30.00 price objective (up previously from $23.00) on shares of Tenet Healthcare Corporation in a research note on Sunday, August 20th. Royal Bank Of Canada restated a hold rating and set a $25.00 price target on shares of Tenet Healthcare Corporation in a research report on Thursday, August 24th. Mizuho restated a neutral rating and set a $14.00 price target on shares of Tenet Healthcare Corporation in a research report on Sunday, August 20th. Finally, Credit Suisse Group dropped their price target on shares of Tenet Healthcare Corporation from $20.00 to $17.00 and set a neutral rating on the stock in a research report on Wednesday, August 9th. Three research analysts have rated the stock with a sell rating, nine have issued a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. Tenet Healthcare Corporation currently has a consensus rating of Hold and an average price target of $21.43.

Shares of Tenet Healthcare Corporation (NYSE:THC) opened at 18.12 on Friday. The company has a 50 day moving average price of $16.83 and a 200 day moving average price of $17.76. Tenet Healthcare Corporation has a 1-year low of $12.54 and a 1-year high of $24.86. The company’s market capitalization is $1.83 billion.

Tenet Healthcare Corporation (NYSE:THC) last released its quarterly earnings data on Monday, August 7th. The company reported ($0.17) earnings per share for the quarter, hitting the Zacks’ consensus estimate of ($0.17). The firm had revenue of $14.80 billion for the quarter, compared to analyst estimates of $4.90 billion. Tenet Healthcare Corporation had a negative net margin of 0.97% and a negative return on equity of 2.00%. The business’s quarterly revenue was up 204.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.38 earnings per share. Equities analysts predict that Tenet Healthcare Corporation will post $0.83 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Tenet Healthcare Corporation (THC) Rating Reiterated by Deutsche Bank AG” was originally published by Daily Political and is owned by of Daily Political. If you are accessing this report on another website, it was illegally copied and republished in violation of United States & international copyright & trademark legislation. The correct version of this report can be accessed at https://www.dailypolitical.com/2017/09/05/tenet-healthcare-corporation-thc-rating-reiterated-by-deutsche-bank-ag.html.

Several hedge funds and other institutional investors have recently made changes to their positions in THC. FNY Managed Accounts LLC acquired a new stake in shares of Tenet Healthcare Corporation in the first quarter valued at about $109,000. PNC Financial Services Group Inc. grew its position in shares of Tenet Healthcare Corporation by 52.1% in the first quarter. PNC Financial Services Group Inc. now owns 6,618 shares of the company’s stock valued at $117,000 after purchasing an additional 2,266 shares during the period. Nomura Asset Management Co. Ltd. grew its position in shares of Tenet Healthcare Corporation by 57.4% in the first quarter. Nomura Asset Management Co. Ltd. now owns 7,100 shares of the company’s stock valued at $126,000 after purchasing an additional 2,590 shares during the period. Riverhead Capital Management LLC grew its position in shares of Tenet Healthcare Corporation by 67.3% in the second quarter. Riverhead Capital Management LLC now owns 7,861 shares of the company’s stock valued at $152,000 after purchasing an additional 3,161 shares during the period. Finally, Flinton Capital Management LLC grew its position in shares of Tenet Healthcare Corporation by 65.7% in the second quarter. Flinton Capital Management LLC now owns 7,888 shares of the company’s stock valued at $153,000 after purchasing an additional 3,128 shares during the period.

Tenet Healthcare Corporation Company Profile

Tenet Healthcare Corporation (Tenet) is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States. The Company’s segments include Hospital Operations and Other, Ambulatory Care and Conifer. As of December 31, 2016, its subsidiaries operated 79 hospitals, including three academic medical centers, two children’s hospitals, two specialty hospitals and one critical access hospital.

Analyst Recommendations for Tenet Healthcare Corporation (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.